BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38068990)

  • 1.
    Xi H; Fu Y; Chen C; Feng X; Han W; Gu J; Ji Y
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068990
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel lysin Ply1228 provides efficient protection against Streptococcus suis type 2 infection in a murine bacteremia model.
    Wang Z; Liu X; Shi Z; Zhao R; Ji Y; Tang F; Guan Y; Feng X; Sun C; Lei L; Han W; Du XD; Gu J
    Vet Microbiol; 2022 May; 268():109425. PubMed ID: 35397385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute meningitis of piglets and mice caused by co-infected with Streptococcus suis and Aerococcus viridans.
    Pan Z; Ma Y; Ma J; Dong W; Yao H
    Microb Pathog; 2017 May; 106():60-64. PubMed ID: 27816682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcus suis prophage lysin as a new strategy for combating streptococci-induced mastitis and Streptococcus suis infection.
    Li XX; Zhang FQ; Wang S; Duan XC; Hu DY; Gao DY; Tao P; Li XM; Qian P
    J Antimicrob Chemother; 2023 Mar; 78(3):747-756. PubMed ID: 36659862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Phage Lysin PlySs2 Decolonizes Streptococcus suis from Murine Intranasal Mucosa.
    Gilmer DB; Schmitz JE; Thandar M; Euler CW; Fischetti VA
    PLoS One; 2017; 12(1):e0169180. PubMed ID: 28046082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel prophage lysin Ply5218 with extended lytic activity and stability against Streptococcus suis infection.
    Zhang H; Zhang C; Wang H; Yan YX; Sun J
    FEMS Microbiol Lett; 2016 Sep; 363(18):. PubMed ID: 27481700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the Phage Lysin Ply5218 in the Treatment of
    Wang Z; Ma J; Wang J; Yang D; Kong L; Fu Q; Cheng Y; Wang H; Yan Y; Sun J
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31387285
    [No Abstract]   [Full Text] [Related]  

  • 8. Amentoflavone Ameliorates Streptococcus suis-Induced Infection
    Shen X; Niu X; Li G; Deng X; Wang J
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30315078
    [No Abstract]   [Full Text] [Related]  

  • 9. Effective Antibacterial and Antihemolysin Activities of Ellipticine Hydrochloride against Streptococcus suis in a Mouse Model.
    Wang C; Lu H; Liu M; Wang G; Li X; Lu W; Dong W; Wang X; Chen H; Tan C
    Appl Environ Microbiol; 2021 Apr; 87(10):. PubMed ID: 33674433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Csl2, a novel chimeric bacteriophage lysin to fight infections caused by Streptococcus suis, an emerging zoonotic pathogen.
    Vázquez R; Domenech M; Iglesias-Bexiga M; Menéndez M; García P
    Sci Rep; 2017 Nov; 7(1):16506. PubMed ID: 29184097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.
    Gilmer DB; Schmitz JE; Euler CW; Fischetti VA
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2743-50. PubMed ID: 23571534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophage lysin Ply30 protects mice from Streptococcus suis and Streptococcus equi subsp. zooepidemicus infections.
    Tang F; Li D; Wang H; Ma Z; Lu C; Dai J
    Appl Environ Microbiol; 2015 Nov; 81(21):7377-84. PubMed ID: 26253669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purified recombinant phage lysin LySMP: an extensive spectrum of lytic activity for swine streptococci.
    Wang Y; Sun JH; Lu CP
    Curr Microbiol; 2009 Jun; 58(6):609-15. PubMed ID: 19267155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of extended binding affinity of prophage lysin PlyARI against Streptococcus suis infection.
    Xiao Y; Chen R; Li M; Qi Z; Yu Y; Pan Z; Yao H; Feng Z; Zhang W
    Arch Microbiol; 2021 Oct; 203(8):5163-5172. PubMed ID: 34338822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of nisin against the swine pathogen Streptococcus suis and its synergistic interaction with antibiotics.
    Lebel G; Piché F; Frenette M; Gottschalk M; Grenier D
    Peptides; 2013 Dec; 50():19-23. PubMed ID: 24096107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin reduces Streptococcus suis virulence by inhibiting suilysin activity and inflammation.
    Li G; Shen X; Wei Y; Si X; Deng X; Wang J
    Int Immunopharmacol; 2019 Apr; 69():71-78. PubMed ID: 30682719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR transactivation contributes to neuroinflammation in Streptococcus suis meningitis.
    Yang XP; Fu JY; Yang RC; Liu WT; Zhang T; Yang B; Miao L; Dou BB; Tan C; Chen HC; Wang XR
    J Neuroinflammation; 2016 Oct; 13(1):274. PubMed ID: 27756321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel endolysin disrupts Streptococcus suis with high efficiency.
    Ji W; Huang Q; Sun L; Wang H; Yan Y; Sun J
    FEMS Microbiol Lett; 2015 Dec; 362(24):fnv205. PubMed ID: 26534896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial Effects of Phage Lysin LysGH15 on Planktonic Cells and Biofilms of Diverse Staphylococci.
    Zhang Y; Cheng M; Zhang H; Dai J; Guo Z; Li X; Ji Y; Cai R; Xi H; Wang X; Xue Y; Sun C; Feng X; Lei L; Han W; Gu J
    Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29776929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-pathogen Interaction at the Intestinal Mucosa Correlates With Zoonotic Potential of Streptococcus suis.
    Ferrando ML; de Greeff A; van Rooijen WJ; Stockhofe-Zurwieden N; Nielsen J; Wichgers Schreur PJ; Pannekoek Y; Heuvelink A; van der Ende A; Smith H; Schultsz C
    J Infect Dis; 2015 Jul; 212(1):95-105. PubMed ID: 25525050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.